Dimensional Fund Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Dimensional Fund Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30,637	Closed	-$551K	–	3400
2020 Q2	$551K	Hold	30,637	–	–	﹤0.01%	3062
2020 Q1	$218K	Buy	+30,637	New	+$382K	﹤0.01%	3199
2018 Q1	–	Sell	-13,307	Closed	-$648K	–	3365
2017 Q4	$648K	Buy	13,307 +1,060	+9%	+$53.6K	﹤0.01%	3061
2017 Q3	$662K	Buy	+12,247	New	+$719K	﹤0.01%	3066

Dimensional Fund Advisors's PTLA Position: Q3 2020 in Review

Dimensional Fund Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 30,637 shares — an estimated $551K sold.

Dimensional Fund Advisors first reported a position in PTLA in Q3 2017 and held it in 4 quarters. The position peaked at $662K in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Dimensional Fund Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Dimensional Fund Advisors sold 30,637 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $551K.
Dimensional Fund Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 4 quarters.
Dimensional Fund Advisors's Portola Pharmaceuticals, Inc. position peaked at $662K in Q3 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Dimensional Fund Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.